Filing Details
- Accession Number:
- 0001209191-21-004769
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-21 21:00:12
- Reporting Period:
- 2021-01-19
- Accepted Time:
- 2021-01-21 21:00:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1478320 | Adaptive Biotechnologies Corp | ADPT | Biological Products, (No Disgnostic Substances) (2836) | 270907024 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1780790 | Louise Nancy Hill | C/O Adaptive Biotechnologies Corp. Suite 200 Seattle WA 98102 | Evp, Operations & Program Mana | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-01-19 | 2,000 | $0.84 | 12,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-01-19 | 23,000 | $4.07 | 35,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-01-19 | 25,000 | $69.00 | 10,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-01-19 | 2,000 | $0.00 | 2,000 | $0.84 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-01-19 | 23,000 | $0.00 | 23,000 | $4.07 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-11-03 | No | 4 | M | Direct | |
| 27,000 | 2025-04-17 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 500 | Indirect | By Ryan Hill (son) |
| Common Stock | 400 | Indirect | By Brandon Hill (son) |
| Common Stock | 300 | Indirect | By Connor Hill (son) |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020.
- The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.
- The option is fully vested and exercisable.
Billionaire Hedge Funds
